All News

Found 554,237 articles

• CENTOGENE Welcomes Germany’s Chancellor Dr. Angela Merkel

  5/23/2019

  CENTOGENE welcomed Germany’s Chancellor Dr. Angela Merkel to its headquarters together with Manuela Schwesig, Minister-President of Mecklenburg-Vorpommern.

• Polarean Imaging Plc London Investor Symposium Wednesday 12 June 2019

  5/23/2019

  Polarean Imaging plc, the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging market, announces it will be hosting a Capital Markets Day for all investors on Wednesday 12 June 2019.

• Auris Medical Holding Ltd Provides Corporate Update

  5/23/2019

  Auris Medical Holding Ltd. provided a business update, including a review of recent clinical, regulatory and operational highlights and progress.

• InflaRx Reports First Quarter 2019 Financial & Operating Results

  5/23/2019

  InflaRx reported financial and operating results for the first quarter ended March 31, 2019.

• Medtronic Reports Fiscal Year and Fourth Quarter 2019 Financial Results

  5/23/2019

  Medtronic plc announced financial results for its fiscal year and fourth quarter 2019, which ended April 26, 2019.

• Credentis and DentaQuest Partner to Bring Innovative Cavity Prevention Products to US Markets

  5/23/2019

  credentis, a leader in state-of-the-art oral biology research and development, and DentaQuest, the nation’s leading purpose-driven oral health care organization, have entered into a strategic partnership to test and promote Curodont™ Repair Fluoride Plus and other Curolox® products in the North American Market, enabling better pre-cavity treatment and prevention for US consumers.

• Self-Destructing Molecules Hold Key to Retard Superbug Development

  5/23/2019

  Singapore-based researchers have discovered a possible solution to impede the evolution of bacteria into superbugs that are resistant to drugs and therefore harder to kill.

• Molecules Swing Electrolytes across Membranes to Kill Cancer Cells

  5/23/2019

  Researchers from Singapore have designed the world’s first ‘molecular swing’ to transport electrolytes across cell membranes.

• BioArctic strengthens its blood-brain barrier technology platform with world leading scientist recruitment

  5/23/2019

  BioArctic AB announced that the company has recruited the internationally renowned scientist Dr. Per-Ola Freskgård to strengthen BioArctic’s development of its technology platform to facilitate passage of antibodies and other biologics across the blood-brain barrier.

• MorphoSys AG Reports Outcome of Annual General Meeting 2019

  5/23/2019

  All Resolutions Proposed by the Company's Management Approved

• IQVIA to Participate in William Blair Growth Stock Conference on June 5, 2019

  5/23/2019

  IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ari Bousbib, chairman and chief executive officer, will speak at the William Blair 39th Annual Growth Stock Conference in Chicago, IL on Wednesday, June 5, 2019 at 10:40 a.m. CT / 11:40 a.m. ET.

• Amprion Joins the Fight Against Parkinson's Through Early Detection Testing

  5/23/2019

  Amprion today announced its proprietary technology, Protein Misfolding Cyclic Amplification (PMCA) using CSF and plasma alpha-Synuclein (αS) to aid in the diagnosis of Parkinson's disease, received a Breakthrough Device designation from U.S. FDA.

• PPG Launches Paints with Purpose

  5/23/2019

  PPG (NYSE: PPG) today launched its Paints with Purpose campaign, which will showcase the many unexpected applications of next-generation paint and coatings technologies.

• Comedy vs Cancer Surpasses $1 Million For Cancer Research at Memorial Sloan Kettering Cancer Center

  5/23/2019

  Comedy vs Cancer, a night of humor and hope to outwit blood cancers, raised more than $1 million for research at Memorial Sloan Kettering Cancer Center. There were 1,000 people in the audience for the sold-out show in New York City on Tuesday, May 14 at Jazz at Lincoln Center's Frederick P. Rose Hall.

• FDA permits marketing of first diagnostic test to aid in detecting prosthetic joint infections

  5/23/2019

  Today, the U.S. Food and Drug Administration permitted marketing of the Synovasure Lateral Flow Test Kit as an aid for the detection of periprosthetic joint infection (infection around a joint replacement) in the synovial (lubricant) fluid of patients being evaluated for revision surgery, which is surgery performed to replace or compensate for a failed implant.

• LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Intersect ENT, Inc. To Contact The Firm

  5/23/2019

   Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Intersect ENT, Inc. ("Intersect" or the "Company") (NASDAQ:XENT) of the July 15, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

• HCP Announces Closing of Upsized $2.5 Billion Revolving Credit Facility and New $250 Million Term Loan Facility

  5/23/2019

  HCP, Inc. (NYSE: HCP) announced today that it has closed an amended and restated credit agreement providing for a $2.5 billion unsecured revolving credit facility and a new $250 million unsecured term loan facility (collectively, the "Credit Facilities").

• Bio-Rad to Participate at Jefferies 2019 Global Healthcare Conference on June 4

  5/23/2019

  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, and Ilan Daskal, Executive Vice President and CFO, will participate in Jefferies 2019 Global Healthcare Conference on Tuesday, June 4, at 10 AM (Eastern Time), in New York, NY.

• Precious Investments, Inc., Completes Name Change and Corporate Changes

  5/23/2019

  Cannagistics, Inc. (OTCBB Markets “CNGT”) (the “Company” or “Cannagistics”), announces the completion, as of May 17, 2019, of the change of the corporate name from Precious Investments, Inc., to Cannagistics, Inc. FINRA assigned a new stock symbol, that being: “CNGT” to the Company.

• American Well Telehealth App Now Available in Epic App Orchard

  5/23/2019

   National telehealth leader American Well® announced today the launch of its leading virtual care platform in Epic's App Orchard.